Triumeq in Amyotrophic Lateral Sclerosis

Clinical trial NCT05193994 · TERMINATED

Trial details

NCT number: NCT05193994
Sponsor: Macquarie University, Australia
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2022-02-24
Primary completion: 2025-06-30
Enrollment: 419

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.